Edward Wang, MD
Urology · San Jose
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 34
- 9 carriers
- Office
- 1
Offices
1 location
Looking this up.
Hospitals listed: El Camino Health. That is not proof they admit you there this week.
Plans that list them
34 plans · 9 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Wang’s office at (669) 213-6231 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
34 of 34 plans
| Aetna Medicare Enhanced (HMO-POS) | Aetna Medicare | Listed | Sep 8, 2026 |
| Aetna Medicare Enhanced Extra (HMO-POS) | Aetna Medicare | Listed | Sep 8, 2026 |
| Alignment Health Advantage PPO (PPO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Sutter Advantage +More (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Medicare Advantage (HMO-POS) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Prime (HMO-POS) | Anthem Blue Cross Partnership Plan | Listed | Oct 3, 2026 |
| Astiva Health C-SNP WOW - NorCal (HMO C-SNP) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Premier Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Savings Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Blue Shield Inspire (HMO) | Blue Shield of California | Listed | Aug 26, 2026 |
| Central Health Classic Care Plan III (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Dual Access Plan (HMO D-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Embrace Choice Plan (HMO C-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Valor Care Plan (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence G54057 · Current
Licensed to practise in California · since 1984 · expires 2028-03-31 · Rosalind Franklin University, the Chicago Medical School.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- El Camino HealthMountain View, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of El Camino Health, which runs 2 hospitalsPatients rate it 4 of 5 · 80% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.291, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.393, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0, Oct 2024 – Sep 2025
See every measure and the patient survey for El Camino Health
Behind the star rating — Deaths: 3 better, 5 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 1 better, 9 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.291 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.393 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.96 (0.12 to 1.79) · 2,340 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.02 (0.76 to 1.28) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 167.38 (125.03 to 209.73) · 96 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.6 · 68 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 185 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.9 · 814 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13 · 842 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.6 · 361 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.6 · 4,633 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.34) · 11,474 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.1 to 0.45) · 11,626 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.14 (1.39 to 4.9) · 2,814 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2 (0.61 to 3.39) · 1,327 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.8 to 3.43) · 2,641 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.39 (4.18 to 14.6) · 1,287 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.57 (3.47 to 9.68) · 1,308 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.14 (0.71 to 3.57) · 827 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.6 (0.05 to 1.15) · 9,460 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.5 · 122 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.993 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.706 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.376 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.5 · 218 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.5 · 962 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 3.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -17 · 922 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 18.6 · 860 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.7 · 827 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.1 (4.5 to 8.2) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 13.4 (10.6 to 16.5) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.1 · 144 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.3 · 80 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.7 · 237 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.8 (10 to 16.1) · 1,639 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.8 to 1.1) · 1,619 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,535 patients answered, 22% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 76% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 75% |
| Nurses "always" listened carefully | 76% |
| Nurses "always" treated them with courtesy and respect | 87% |
| "Always" quiet at night | 47% |
| "YES", patients would definitely recommend the hospital | 80% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
Original Medicare doctor bills
$85,799
Medicare paid this office $85,799 for 207 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 106 | $17,727 | $118 |
| Short return visit (20+ min) | 89 | $12,161 | $77 |
| New patient visit (45+ min) | 55 | $8,498 | $155 |
| Diagnostic exam of bladder and urethra using an endoscope | 29 | $6,962 | $240 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 14 | $2,002 | $143 |
See all 8 services
| Return visit (30+ min) | 106 | $17,727 | $118 |
| Short return visit (20+ min) | 89 | $12,161 | $77 |
| New patient visit (45+ min) | 55 | $8,498 | $155 |
| Diagnostic exam of bladder and urethra using an endoscope | 29 | $6,962 | $240 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 14 | $2,002 | $143 |
| New patient visit (30+ min) | 21 | $1,489 | $71 |
| Simple insertion of temporary bladder tube | 11 | $1,088 | $64 |
| Ultrasound measurement of bladder capacity after voiding | 42 | $510 | $12 |
Procedures Medicare counted
| Prostate resection | 67 | More than 98% of doctors who do this |
Who their Medicare patients are
207 Original Medicare patients in 2024. Average age 77 · Women 21% · Also on Medicaid 73% · Health risk score 1.45. Above the middle of the specialty; the typical urology clinician is at 1.36.
Conditions among them: High blood pressure 75% · Diabetes 53% · Chronic kidney disease 36% · Coronary heart disease 23% · Atrial fibrillation 20% · Cancer 19% · Dementia 17% · COPD 14% · Depression 14% · Heart failure 12% · Stroke 10%.
The office billed $205,804, Medicare allowed $113,090 and paid $85,799; for 694 services of 36 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 207 | 694 | 77 | 1.45 | $205,804 | $85,799 |
| 2023 | 199 | 458 | 77 | 1.73 | $165,218 | $54,323 |
| 2022 | 209 | 511 | 77 | 1.76 | $163,734 | $58,995 |
| 2021 | 113 | 293 | 77 | 1.79 | $86,534 | $37,076 |
| 2020 | 87 | 247 | 77 | 1.91 | $73,227 | $24,697 |
| 2019 | 469 | 4,926 | 74 | 1.91 | $750,019 | $174,890 |
| 2018 | 502 | 9,671 | 74 | 1.68 | $698,347 | $172,941 |
| 2017 | 380 | 5,379 | 74 | 1.79 | $486,463 | $126,380 |
| 2016 | 394 | 4,604 | 74 | 1.78 | $417,226 | $116,560 |
| 2015 | 431 | 1,255 | 73 | 1.72 | $376,280 | $118,179 |
| 2014 | 314 | 978 | 72 | 1.51 | $231,689 | $85,733 |
| 2013 | 321 | 1,050 | 74 | 1.38 | $222,766 | $80,249 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 6 services
| Short return visit (20+ min) | 80 | $8,504 | $77 |
| Return visit (30+ min) | 69 | $8,324 | $96 |
| Diagnostic exam of bladder and urethra using an endoscope | 30 | $5,997 | $193 |
| New patient visit (30+ min) | 50 | $4,374 | $87 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 24 | $2,689 | $112 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 14 | $1,079 | $72 |
2022: 9 services
| New patient visit (30+ min) | 104 | $9,990 | $96 |
| Diagnostic exam of bladder and urethra using an endoscope | 37 | $9,060 | $238 |
| Short return visit (20+ min) | 62 | $8,364 | $85 |
| Return visit (30+ min) | 38 | $5,383 | $117 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 14 | $2,513 | $180 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 17 | $2,058 | $114 |
| New patient visit (45+ min) | 11 | $1,740 | $158 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 11 | $1,062 | $71 |
| Ultrasound measurement of bladder capacity after voiding | 12 | $138 | $11 |
2021: 5 services
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 34 | $5,787 | $152 |
| Diagnostic exam of bladder and urethra using an endoscope | 18 | $4,420 | $233 |
| Return visit (30+ min) | 23 | $4,221 | $121 |
| Short return visit (20+ min) | 25 | $3,462 | $81 |
| New patient visit (30+ min) | 25 | $2,540 | $102 |
2020: 4 services
| New patient visit (30+ min) | 23 | $2,441 | $106 |
| Diagnostic exam of bladder and urethra using an endoscope | 11 | $2,362 | $215 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 12 | $2,152 | $166 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 20 | $1,787 | $89 |
2019: 23 services
| Return visit (30+ min) | 237 | $30,053 | $94 |
| Diagnostic exam of bladder and urethra using an endoscope | 112 | $22,295 | $176 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 13 | $17,450 | None |
| Removal of prostate gland using an electrocautery knife through urethra with control of bleeding using an endoscope | 16 | $10,410 | $651 |
| Crushing of stone of ureter with insertion of stent using an endoscope | 22 | $8,226 | $358 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 51 | $4,643 | $88 |
| New patient visit (30+ min) | 47 | $4,235 | $90 |
| Insertion of stent in ureter using an endoscope | 25 | $3,908 | $126 |
| Simple insertion of temporary bladder tube | 23 | $3,538 | $54 |
| Simple removal of foreign body, stone, or stent in urethra or bladder using an endoscope | 14 | $3,315 | $237 |
| Biopsy of prostate gland | 12 | $2,799 | $233 |
| Simple change of bladder tube | 15 | $2,129 | $89 |
| Short return visit (20+ min) | 27 | $1,930 | $67 |
| Simple bladder irrigation and/or instillation | 24 | $1,860 | $72 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 21 | $1,831 | $28 |
| Ultrasound scan of pelvic region through rectum | 14 | $1,760 | $126 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 18 | $1,207 | $64 |
| Imaging of urinary tract following injection of a contrast agent | 42 | $1,164 | $23 |
| Ultrasound measurement of bladder capacity after voiding | 83 | $1,096 | $11 |
| Manual urinalysis test with examination using microscope, non-automated | 217 | $1,089 | $4 |
| Injection of drug or substance under skin or into muscle | 14 | $461 | $15 |
| Electronic assessment of bladder emptying | 34 | $213 | $6 |
| Injection, ceftriaxone sodium, per 250 mg | 11 | $20 | None |
2018: 23 services
| Return visit (30+ min) | 190 | $22,444 | $91 |
| Diagnostic exam of bladder and urethra using an endoscope | 140 | $22,184 | $150 |
| Injection, degarelix, 1 mg | 21 | $18,117 | None |
| Leuprolide acetate (for depot suspension), 7.5 mg | 15 | $13,752 | None |
| New patient visit (30+ min) | 147 | $13,519 | $92 |
| Removal of prostate gland using an electrocautery knife through urethra with control of bleeding using an endoscope | 18 | $11,389 | $633 |
| Crushing of stone of ureter with insertion of stent using an endoscope | 16 | $6,082 | $358 |
| Biopsy of prostate gland | 19 | $4,424 | $233 |
| Simple insertion of temporary bladder tube | 28 | $4,090 | $58 |
| Simple removal of foreign body, stone, or stent in urethra or bladder using an endoscope | 17 | $3,847 | $226 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 31 | $3,377 | $29 |
| Short return visit (20+ min) | 46 | $2,840 | $57 |
| Insertion of stent in ureter using an endoscope | 19 | $2,355 | $102 |
| Ultrasound scan of pelvic region through rectum | 25 | $2,319 | $93 |
| Ultrasound measurement of bladder capacity after voiding | 110 | $2,061 | $15 |
| Insertion of temporary bladder tube | 36 | $1,739 | $43 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 19 | $1,645 | $87 |
| Simple bladder irrigation and/or instillation | 18 | $1,401 | $70 |
| Manual urinalysis test with examination using microscope, non-automated | 170 | $762 | $4 |
| Injection of drug or substance under skin or into muscle | 19 | $627 | $17 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 17 | $367 | $20 |
| Electronic assessment of bladder emptying | 50 | $342 | $7 |
| Imaging of urinary tract following injection of a contrast agent | 11 | $201 | $15 |
2017: 17 services
| Return visit (30+ min) | 179 | $21,301 | $88 |
| Diagnostic exam of bladder and urethra using an endoscope | 101 | $15,883 | $144 |
| Removal of prostate gland using an electrocautery knife through urethra with control of bleeding using an endoscope | 12 | $8,848 | $737 |
| New patient visit (30+ min) | 65 | $6,138 | $94 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 56 | $4,903 | $86 |
| Short return visit (20+ min) | 45 | $3,076 | $64 |
| Insertion of stent in ureter using an endoscope | 18 | $2,444 | $116 |
| Simple insertion of temporary bladder tube | 18 | $2,028 | $60 |
| Long return visit (40+ min) | 13 | $1,897 | $126 |
| Ultrasound measurement of bladder capacity after voiding | 82 | $1,635 | $17 |
| Ultrasound scan of pelvic region through rectum | 13 | $1,120 | $86 |
| Injection of drug or substance under skin or into muscle | 18 | $1,029 | $24 |
| Complicated insertion of bladder tube | 15 | $1,005 | $67 |
| Short return visit | 17 | $683 | $38 |
| Insertion of temporary bladder tube | 11 | $571 | $44 |
| Manual urinalysis test with examination using microscope, non-automated | 89 | $422 | $4 |
| Electronic assessment of bladder emptying | 27 | $205 | $8 |
2016: 16 services
| Return visit (30+ min) | 204 | $24,302 | $89 |
| Diagnostic exam of bladder and urethra using an endoscope | 96 | $19,480 | $186 |
| New patient visit (30+ min) | 51 | $4,784 | $94 |
| Biopsy of prostate gland | 14 | $2,808 | $201 |
| Short return visit (20+ min) | 39 | $2,671 | $62 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 29 | $2,604 | $87 |
| Simple insertion of temporary bladder tube | 23 | $2,122 | $66 |
| Ultrasound measurement of bladder capacity after voiding | 80 | $1,543 | $17 |
| Injection of drug or substance under skin or into muscle | 17 | $1,508 | $23 |
| Ultrasound scan of pelvic region through rectum | 15 | $1,394 | $87 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 11 | $1,299 | $118 |
| Insertion of temporary bladder tube | 17 | $1,029 | $51 |
| Ultrasonic guidance for needle placement | 13 | $710 | $55 |
| Short return visit | 13 | $521 | $40 |
| Manual urinalysis test with examination using microscope, non-automated | 44 | $203 | $4 |
| Electronic assessment of bladder emptying | 23 | $169 | $7 |
2015: 16 services
| Return visit (30+ min) | 219 | $26,996 | $88 |
| Diagnostic exam of bladder and urethra using an endoscope | 92 | $18,792 | $177 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 68 | $12,335 | $169 |
| Removal of prostate gland using an electrocautery knife through urethra with control of bleeding using an endoscope | 16 | $11,229 | $702 |
| New patient visit (30+ min) | 53 | $4,754 | $90 |
| New patient visit (45+ min) | 23 | $2,640 | $115 |
| Insertion of stent in ureter using an endoscope | 15 | $1,816 | $107 |
| Short return visit (20+ min) | 20 | $1,304 | $59 |
| Injection of drug or substance under skin or into muscle | 13 | $1,296 | $22 |
| Ultrasound measurement of bladder capacity after voiding | 60 | $1,262 | $18 |
| Short return visit | 13 | $782 | $39 |
| Manual urinalysis test with examination using microscope, non-automated | 147 | $776 | $4 |
| Return visit (30+ min) | 12 | $645 | $46 |
| Insertion of temporary bladder tube | 12 | $582 | $48 |
| Ultrasound scan of pelvic region through rectum | 11 | $377 | $31 |
| Electronic assessment of bladder emptying | 34 | $122 | $3 |
2014: 12 services
| Return visit (30+ min) | 150 | $18,376 | $83 |
| Diagnostic exam of bladder and urethra using an endoscope | 62 | $11,575 | $173 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 36 | $6,337 | $171 |
| New patient visit (45+ min) | 38 | $5,312 | $140 |
| Short return visit (20+ min) | 23 | $1,948 | $63 |
| Simple insertion of temporary bladder tube | 16 | $1,821 | $57 |
| Return visit (30+ min) | 22 | $1,139 | $52 |
| New patient visit (30+ min) | 19 | $992 | $52 |
| Manual urinalysis test with examination using microscope, non-automated | 138 | $762 | $4 |
| Ultrasound measurement of bladder capacity after voiding | 38 | $701 | $16 |
| Diagnostic exam of bladder and urethra using an endoscope | 15 | $463 | $29 |
| Electronic assessment of bladder emptying | 26 | $96 | $4 |
2013: 14 services
| Diagnostic exam of bladder and urethra using an endoscope | 79 | $15,477 | $172 |
| Return visit (30+ min) | 121 | $13,398 | $88 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 41 | $7,236 | $168 |
| Short return visit | 79 | $3,028 | $34 |
| New patient visit (45+ min) | 19 | $2,529 | $133 |
| Insertion of stent in ureter using an endoscope | 12 | $1,500 | $107 |
| Short return visit (20+ min) | 17 | $1,406 | $64 |
| Simple insertion of temporary bladder tube | 14 | $1,339 | $58 |
| Manual urinalysis test with examination using microscope, non-automated | 167 | $947 | $4 |
| Prostate cancer screening; digital rectal examination | 49 | $826 | $17 |
| Return visit (30+ min) | 15 | $758 | $51 |
| Ultrasound measurement of bladder capacity after voiding | 39 | $662 | $17 |
| Imaging of urinary tract following injection of a contrast agent | 11 | $178 | $15 |
| Electronic assessment of bladder emptying | 32 | $106 | $3 |
Medicaid work
$27 in 2024
Medicaid paid $27 for 94 billed services this clinician did in 2024, up to 15 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Short return visit (20+ min) | 54 | $27 |
| Return visit (30+ min) | 40 | $0 |
| 2024 | 94 | 2 | 15 | $27 |
| 2023 | 163 | 2 | 19 | $399 |
| 2022 | 192 | 2 | 26 | $146 |
| 2020 | 130 | 3 | 24 | $5,895 |
| 2019 | 879 | 5 | 33 | $33,940 |
| 2018 | 586 | 5 | 44 | $24,948 |
See the largest Medicaid services in earlier years
2023
| Return visit (30+ min) | 40 | $211 |
| Short return visit (20+ min) | 123 | $188 |
2022
| New patient visit (30+ min) | 108 | $115 |
| Short return visit (20+ min) | 84 | $31 |
2020
| Short return visit (20+ min) | 79 | $3,003 |
| New patient visit (30+ min) | 30 | $2,805 |
| Urinalysis, by dip stick or tablet reagent for bilirubin, glucose, hemoglobin, ketones, leukocytes, nitrite, pH, protein, specific gravity, urobilinogen, any number of these constituents; non-automated, with microscopy | 21 | $87 |
2019
| New patient visit (30+ min) | 176 | $15,683 |
| Short return visit (20+ min) | 289 | $11,098 |
| Return visit (30+ min) | 102 | $4,647 |
| CYSTOURETHROSCOPY | 12 | $1,388 |
| Urinalysis, by dip stick or tablet reagent for bilirubin, glucose, hemoglobin, ketones, leukocytes, nitrite, pH, protein, specific gravity, urobilinogen, any number of these constituents; non-automated, with microscopy | 300 | $1,124 |
2018
| New patient visit (30+ min) | 126 | $10,549 |
| Short return visit (20+ min) | 273 | $10,054 |
| Return visit (30+ min) | 54 | $3,165 |
| Measurement of post-voiding residual urine and/or bladder capacity by ultrasound, non-imaging | 13 | $706 |
| Urinalysis, by dip stick or tablet reagent for bilirubin, glucose, hemoglobin, ketones, leukocytes, nitrite, pH, protein, specific gravity, urobilinogen, any number of these constituents; non-automated, with microscopy | 120 | $475 |
Drugs they prescribed that Part D paid
$634,240
Pharmacies billed $634,240 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 3% of their Part D prescriptions (31 of 1,074) in 2024. Above the middle of the specialty; the typical urology clinician is at 2%.
951 generic and 123 brand-name prescriptions · $634,240 in drug cost · 113 antibiotic prescriptions to 86 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Erleada | 38 | $529,368 | $13,931 |
| Myrbetriq | 44 | $27,066 | $615 |
| Premarin | 28 | $11,549 | $412 |
| Tamsulosin | 272 | $4,182 | $15 |
| Finasteride | 240 | $3,904 | $16 |
See all 15 drugs
| Erleada | 38 | $529,368 | $13,931 |
| Myrbetriq | 44 | $27,066 | $615 |
| Premarin | 28 | $11,549 | $412 |
| Tamsulosin | 272 | $4,182 | $15 |
| Finasteride | 240 | $3,904 | $16 |
| Estradiol | 65 | $3,309 | $51 |
| Dutasteride | 73 | $2,963 | $41 |
| Bicalutamide | 62 | $1,611 | $26 |
| Doxazosin Mesylate | 11 | $342 | $31 |
| Cephalexin | 54 | $251 | $5 |
| Terazosin | 13 | $182 | $14 |
| Ceftriaxone | 18 | $81 | $4 |
| Ciprofloxacin | 27 | $50 | $2 |
| Hydrocodone-Acetaminophen | 31 | $15 | $0 |
| Diazepam | 11 | $5 | $0 |
Year by year
| 2024 | 1,074 | 352 | 3% (31) | 11% | $634,240 |
| 2023 | 1,030 | 331 | 3% (30) | 9% | $219,656 |
| 2022 | 715 | 246 | 4% (25) | 11% | $103,905 |
| 2021 | 390 | 120 | 7% (29) | None | $55,201 |
| 2020 | 239 | 87 | 5% (12) | 15% | $67,522 |
| 2019 | 438 | 132 | 3% (14) | None | $172,765 |
| 2018 | 485 | 158 | 5% (22) | None | $241,894 |
| 2017 | 397 | 121 | 8% (31) | None | $87,104 |
| 2016 | 396 | 116 | 9% (34) | None | $60,581 |
| 2015 | 470 | 120 | 4% (20) | 35% | $92,772 |
| 2014 | 482 | 124 | 7% (33) | 38% | $112,724 |
| 2013 | 557 | 137 | 8% (43) | None | $94,245 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 15 drugs
| Erleada | 11 | $128,561 | $11,687 |
| Myrbetriq | 47 | $44,535 | $948 |
| Premarin | 28 | $12,325 | $440 |
| Tamsulosin | 329 | $9,320 | $28 |
| Finasteride | 220 | $6,508 | $30 |
| Estradiol | 29 | $3,623 | $125 |
| Dutasteride | 47 | $3,169 | $67 |
| Bicalutamide | 51 | $2,772 | $54 |
| Cephalexin | 53 | $580 | $11 |
| Amoxicillin-Clavulanate Potass | 16 | $197 | $12 |
| Ciprofloxacin | 42 | $133 | $3 |
| Ceftriaxone | 25 | $48 | $2 |
| Hydrocodone-Acetaminophen | 28 | $21 | $1 |
| Lidocaine | 12 | $19 | $2 |
| Ibuprofen | 22 | $13 | $1 |
2022: 13 drugs
| Myrbetriq | 31 | $27,224 | $878 |
| Premarin | 33 | $13,262 | $402 |
| Estradiol | 37 | $4,385 | $119 |
| Tamsulosin | 160 | $4,035 | $25 |
| Finasteride | 142 | $3,837 | $27 |
| Dutasteride | 24 | $1,840 | $77 |
| Ciprofloxacin | 41 | $282 | $7 |
| Amoxicillin-Clavulanate Potass | 11 | $245 | $22 |
| Cephalexin | 34 | $220 | $6 |
| Ceftriaxone | 22 | $95 | $4 |
| Hydrocodone-Acetaminophen | 25 | $49 | $2 |
| Lidocaine | 18 | $43 | $2 |
| Ibuprofen | 24 | $15 | $1 |
2021: 11 drugs
| Myrbetriq | 23 | $21,246 | $924 |
| Firmagon | 12 | $8,235 | $686 |
| Premarin | 15 | $6,094 | $406 |
| Estradiol | 15 | $2,218 | $148 |
| Tamsulosin | 67 | $1,107 | $17 |
| Finasteride | 40 | $843 | $21 |
| Cephalexin | 25 | $188 | $8 |
| Hydrocodone-Acetaminophen | 29 | $112 | $4 |
| Ciprofloxacin | 32 | $87 | $3 |
| Ceftriaxone | 16 | $43 | $3 |
| Ibuprofen | 16 | $8 | $1 |
2020: 6 drugs
| Myrbetriq | 11 | $7,015 | $638 |
| Premarin | 11 | $4,279 | $389 |
| Tamsulosin | 68 | $444 | $7 |
| Finasteride | 29 | $389 | $13 |
| Cephalexin | 14 | $51 | $4 |
| Hydrocodone-Acetaminophen | 12 | $39 | $3 |
2019: 13 drugs
| Elmiron | 19 | $20,498 | $1,079 |
| Myrbetriq | 17 | $14,429 | $849 |
| Premarin | 20 | $8,085 | $404 |
| Vesicare | 12 | $6,367 | $531 |
| Tadalafil | 13 | $2,504 | $193 |
| Tamsulosin | 120 | $1,852 | $15 |
| Finasteride | 48 | $964 | $20 |
| Testosterone Cypionate | 20 | $749 | $37 |
| Terazosin | 23 | $742 | $32 |
| Cephalexin | 11 | $77 | $7 |
| Sulfamethoxazole-Trimethoprim | 13 | $67 | $5 |
| Ciprofloxacin | 13 | $58 | $4 |
| Hydrocodone-Acetaminophen | 11 | $48 | $4 |
2018: 14 drugs
| Xtandi | 18 | $169,823 | $9,435 |
| Vesicare | 28 | $18,860 | $674 |
| Myrbetriq | 35 | $18,647 | $533 |
| Elmiron | 12 | $9,535 | $795 |
| Premarin | 18 | $6,634 | $369 |
| Cialis | 16 | $5,136 | $321 |
| Tamsulosin | 110 | $2,313 | $21 |
| Finasteride | 48 | $1,046 | $22 |
| Terazosin | 30 | $594 | $20 |
| Ciprofloxacin | 18 | $209 | $12 |
| Hydrocodone-Acetaminophen | 17 | $162 | $10 |
| Levofloxacin | 15 | $142 | $9 |
| Sulfamethoxazole-Trimethoprim | 13 | $79 | $6 |
| Cephalexin | 13 | $79 | $6 |
2017: 11 drugs
| Vesicare | 35 | $19,510 | $557 |
| Myrbetriq | 21 | $8,151 | $388 |
| Cialis | 14 | $6,207 | $443 |
| Premarin | 11 | $3,828 | $348 |
| Tamsulosin | 97 | $2,331 | $24 |
| Finasteride | 25 | $502 | $20 |
| Terazosin | 24 | $431 | $18 |
| Hydrocodone-Acetaminophen | 25 | $125 | $5 |
| Cephalexin | 16 | $93 | $6 |
| Ciprofloxacin | 17 | $81 | $5 |
| Levofloxacin | 12 | $62 | $5 |
2016: 12 drugs
| Vesicare | 25 | $12,255 | $490 |
| Firmagon | 20 | $10,876 | $544 |
| Cialis | 16 | $5,765 | $360 |
| Dutasteride-Tamsulosin | 15 | $2,914 | $194 |
| Tamsulosin | 74 | $2,395 | $32 |
| Finasteride | 45 | $985 | $22 |
| Oxybutynin Chloride Er | 12 | $354 | $30 |
| Terazosin | 26 | $294 | $11 |
| Hydrocodone-Acetaminophen | 26 | $237 | $9 |
| Levofloxacin | 17 | $213 | $13 |
| Cephalexin | 18 | $108 | $6 |
| Ciprofloxacin | 12 | $101 | $8 |
2015: 12 drugs
| Firmagon | 42 | $20,513 | $488 |
| Vesicare | 21 | $9,114 | $434 |
| Myrbetriq | 23 | $8,619 | $375 |
| Jalyn | 19 | $5,392 | $284 |
| Tamsulosin | 81 | $3,342 | $41 |
| Potassium Citrate Er | 14 | $1,623 | $116 |
| Finasteride | 56 | $1,255 | $22 |
| Terazosin | 27 | $313 | $12 |
| Ciprofloxacin | 40 | $217 | $5 |
| Hydrocodone-Acetaminophen | 17 | $128 | $8 |
| Cephalexin | 11 | $72 | $7 |
| Sulfamethoxazole-Trimethoprim | 11 | $41 | $4 |
2014: 12 drugs
| Vesicare | 40 | $12,137 | $303 |
| Jalyn | 26 | $6,394 | $246 |
| Avodart | 25 | $4,033 | $161 |
| Premarin | 13 | $2,823 | $217 |
| Tamsulosin | 85 | $2,041 | $24 |
| Potassium Citrate Er | 12 | $1,236 | $103 |
| Finasteride | 38 | $984 | $26 |
| Hydrocodone-Acetaminophen | 26 | $516 | $20 |
| Cephalexin | 25 | $204 | $8 |
| Ciprofloxacin | 31 | $194 | $6 |
| Terazosin | 17 | $192 | $11 |
| Sulfamethoxazole-Trimethoprim | 15 | $68 | $5 |
2013: 11 drugs
| Lupron Depot | 11 | $31,225 | $2,839 |
| Vesicare | 83 | $21,396 | $258 |
| Avodart | 43 | $7,331 | $170 |
| Jalyn | 23 | $4,033 | $175 |
| Tamsulosin | 96 | $2,770 | $29 |
| Finasteride | 55 | $2,080 | $38 |
| Desmopressin Acetate | 13 | $1,021 | $79 |
| Terazosin | 27 | $251 | $9 |
| Ciprofloxacin | 38 | $218 | $6 |
| Hydrocodone-Acetaminophen | 30 | $133 | $4 |
| Cephalexin | 12 | $89 | $7 |
Money from drug and device companies
$667 in 2025
| 2025 | 9 | 17 | None | $667 |
| 2024 | 4 | 9 | None | $425 |
| 2023 | 7 | 11 | None | $406 |
| 2022 | 8 | 15 | None | $405 |
| 2021 | 7 | 8 | None | $203 |
| 2019 | 15 | 36 | None | $1,370 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Janssen Biotech | Rybrevant | $234 | 6 payments
|
| Pfizer | Xtandi | $138 | 3 payments
|
| Astellas Pharma US | Padcev | $115 | 1 payment
|
| Procept Biorobotics | Aquabeam Robotic System | $51 | 2 payments
|
| Cleerly | Cleerly Ischemia | $42 | 1 payment
|
| Teleflex | Barrigel | $25 | 1 payment
|
See all 17 published payments
| Bayer Healthcare Pharmaceuticals | Meals · 2025-12-11 | Nubeqa | $21 |
| Janssen Biotech | Meals · 2025-12-10 | Erleada | $26 |
| Procept Biorobotics | Meals · 2025-11-24 | Aquabeam Robotic System | $21 |
| Pfizer | Meals · 2025-11-19 | Xtandi | $26 |
| Pfizer | Meals · 2025-11-18 | Xtandi | $3 |
| Astellas Pharma US | Meals · 2025-11-05 | Padcev | $115 |
| Pfizer | Meals · 2025-11-01 | Xtandi | $109 |
| Cleerly | Meals · 2025-10-22 | Cleerly Ischemia | $42 |
| Janssen Biotech | Meals · 2025-09-18 | Erleada | $22 |
| Eisai | Meals · 2025-08-13 | Lenvima | $21 |
| Teleflex | Meals · 2025-08-06 | Barrigel | $25 |
| Procept Biorobotics | Meals · 2025-07-30 | Aquabeam Robotic System | $30 |
| Janssen Biotech | Meals · 2025-07-08 | Erleada | $16 |
| Accord Healthcare | Meals · 2025-05-10 | Camcevi | $20 |
| Janssen Biotech | Meals · 2025-04-24 | Rybrevant | $117 |
| Janssen Biotech | Meals · 2025-04-10 | Erleada | $27 |
| Janssen Biotech | Meals · 2025-02-06 | Erleada | $26 |
See earlier years (2024, 2023, 2022, 2021, 2019)
2024: $425
| Janssen Biotech | Erleada | $190 | 5 payments
|
| Accord Healthcare | Camcevi | $125 | 1 payment
|
| AstraZeneca Pharmaceuticals LP | Lynparza | $55 | 1 payment
|
| Astellas Pharma US | Xtandi | $55 | 2 payments
|
2023: $406
| Janssen Biotech | Erleada | $151 | 4 payments
|
| EMD Serono | Bavencio | $106 | 1 payment
|
| Progenics Pharmaceuticals | Pylarify | $43 | 2 payments
|
| UroGen Pharma | None | $36 | 1 payment
|
| Coloplast | Titan | $25 | 1 payment
|
| Bayer Healthcare Pharmaceuticals | Nubeqa | $24 | 1 payment
|
| Palette Life Sciences | None | $21 | 1 payment
|
2022: $405
| Astellas Pharma US | Padcev | $200 | 5 payments
|
| AstraZeneca Pharmaceuticals LP | Lynparza | $44 | 2 payments
|
| Bayer HealthCare Pharmaceuticals | Nubeqa | $41 | 2 payments
|
| Janssen Biotech | Erleada | $40 | 2 payments
|
| Puma Biotechnology | Nerlynx | $28 | 1 payment
|
| Myriad Genetic Laboratories | Brac Cdx | $20 | 1 payment
|
| Takeda Pharmaceuticals U.S.A. | Ninlaro | $18 | 1 payment
|
| Endo Pharmaceuticals | Edex | $13 | 1 payment
|
2021: $203
| Janssen Biotech | Erleada | $54 | 2 payments
|
| Amgen | Nplate | $30 | 1 payment
|
| Ambu | None | $29 | 1 payment
|
| Boston Scientific | General Bph | $24 | 1 payment
|
| Eisai | Lenvima | $24 | 1 payment
|
| Merck Sharp & Dohme | Keytruda | $23 | 1 payment
|
| Incyte | Jakafi | $19 | 1 payment
|
2019: $1,370
| PROCEPT BioRobotics | Aquabeam Robotic System | $404 | 1 payment
|
| Janssen Biotech | Erleada | $308 | 9 payments
|
| Ferring Pharmaceuticals | Nocdurna | $158 | 3 payments
|
| AstraZeneca Pharmaceuticals LP | Lynparza | $125 | 1 payment
|
| Astellas Pharma US | Xtandi | $100 | 6 payments
|
| Boston Scientific | Lithovue | $83 | 4 payments
|
| Dendreon Pharmaceuticals | Provenge | $65 | 3 payments
|
| Antares Pharma | Xyosted | $30 | 2 payments
|
| AbbVie | Lupron Depot | $20 | 1 payment
|
| 180 Medical | Speedicath | $17 | 1 payment
|
| Sagent Pharmaceuticals | Glydo | $15 | 1 payment
|
| C. R. Bard Inc. & Subsidiaries | None | $13 | 1 payment
|
| Photocure | Cysview | $12 | 1 payment
|
| Pfizer | Premarin | $12 | 1 payment
|
| Janssen Pharmaceuticals | Erleada | $9 | 1 payment
|
Professional record
- NPI
- 1972558666
- Licence
- CA G54057California G54057: Current · expires 2028-03-31
- Trained
- Chicago College of Medicine and Surgery, 1980
- Gender
- Male
More record details
- Sole proprietor
- Yes
- Medicaid ID
- CA 00G540570
- Taxonomy
- Urology (208800000X)
- Mailing address
- 1091 Hidden Oaks Dr, Bulverde, TX, 78163
- NPI first listed
- 2006-05-23
- NPI last updated
- 2020-07-06
- NPI record certified
- 2020-07-06
This is when the NPI record was last certified, not a medical board exam.
This office lists an electronic records connection.